23 May, 2025 Most-Favored-Nation, Executive Order 14297|Forward Looking Perspectives for Drug Manufacturers, Pharmacy Benefit Managers, Health Plans, and Pharmacies By Jeffrey Low Jed Smith Katherine Norris Jeffrey Domingo +1 more... Show less On May 12, 2025, U.S. President Donald Trump signed an executive order (EO) titled “Delivering Most-Favored-Nation Prescription Drug...
19 May, 2025 Enhancing Pharmacy Oversight and Auditing Practices By Jeffrey Low Jed Smith The following discussion highlights key compliance considerations for both existing pharmacies and new market entrants looking to thrive...
14 May, 2025 CMS Civil Monetary Penalties and Intermediate Sanctions Issued in 2025 – Themes your Medicare Plan Should Look Out For By Jeffrey Low Dorothy DeAngelis This year there have been several Civil Monetary Penalties1 (CMP) and an Intermediate Sanction2 issued by the Centers for Medicare and...
11 April, 2025 How Health Systems Can Benefit from the Credit Tenant Lease Model for Developing Ambulatory Surgery Centers and Medical Office Buildings By Michael O'Keefe Hospital systems and healthcare providers develop ambulatory buildings for a number of reasons: to expand market share, attract new care...
28 March, 2025 The $15 Dilemma: How Rising Wages are Putting Unprecedented Pressure on Senior Living By Sahithi Tupuri Matt Sgrignari Juliana Malhotra Rick Maicki Keith Jelinek +2 more... Show less Introduction The senior living industry faces unprecedented pressure from rising minimum wages. In an industry already facing high labor...
28 January, 2025 2025 Healthcare Real Estate Strategy Trends By Katie Reilley The Ankura Healthcare Real Estate Strategy team monitors a wide variety of economic indicators to inform clients’ upcoming strategic...
18 December, 2024 Navigating the Complex Landscape: Bona Fide Service Fees, Government Price Reporting, and the Inflation Reduction Act By CJ DeKreek “Manufacturers are responsible for meeting all four parts of the definition of bona fide service fee before a fee can qualify as a bona...
12 November, 2024 Artificial Intelligence: DOJ Update to the Evaluation of Corporate Compliance Programs By Ana Simon Lisa Taylor On Sept. 23, the U.S. Department of Justice (DOJ) updated its Evaluation of Corporate Compliance Programs (ECCP)1 guidance document for...
07 October, 2024 Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q2 2024] By Anthony Metke Robert Mundy Chamira Jayamanne Vin Phan +1 more... Show less Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q2 2024 in the United States....
16 September, 2024 CMS Proposes Protocols for Enhanced Oversight of Medicare Part C Utilization Management Requirements By Kelli Howe In 2024, the Centers for Medicare & Medicaid Services (CMS) leveraged its existing oversight channels1 to assess plans’ compliance with...
10 September, 2024 Leading the ASC Market: Advanced Strategies for Health Systems to Stay Ahead By Erin Nelson Katie Reilley Michelle Mader Between 2023 and 2030, the ambulatory surgery market in the U.S. is expected to grow by nearly 50%, increasing from a market value of $40...
09 September, 2024 Is there room for AI in the ICU? Guiding Principles and Compliance Considerations By Emily Petersen Lisa Taylor Jacqueline Voss Introduction Artificial Intelligence (AI) offers unprecedented opportunities to enhance patient care, streamline clinical documentation,...